Skip to content

PROGRESS PHARMA

Active
Public limited companyfounded 2013active for 13 yearsRoekendreef 14, 2350 Vosselaar, BelgiumKBO/BCE: BE 0536.258.560
Summary

PROGRESS PHARMA has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €47,137 and a net result of -€5,479. Equity is shrinking by about 15% per year across the filed financial years. Its solvency ranks better than 90% of 605 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
PROGRESS PHARMAActiveChecked score 93/100
Risk analysis ReportCompare

History

On 27 June 2013, PROGRESS PHARMA was incorporated.1 Total assets went from €217,064 in 2018 to €49,934 in 2025.2

  1. 1KBO (Crossroads Bank for Enterprises)
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
05-06
NBB filing Annual accounts filed
financial year 2025 · micro format
06-01
Gazette deed Reappointments: Salvegen Healthcare B.V., R&S Consulting and 3 others
Permanent representatives: van Dongen Emilius Hubertus Adrianus Maria, Reyn Dirk Maria Jozef and 2 others · Capital decrease · Amendment of the articles15 facts ▸
  • General meeting, 19-12-2025
  • Capital decrease, €40,000
  • Capital decrease, €398,500
  • Amendment of the articles, 5.1
  • Other provision, “door hen gevoerde beleid, ontslag en kwijting bestuurders” (deed in Dutch)
  • Director reappointment, Salvegen Healthcare B.V. (director)
  • Director reappointment, R&S Consulting (director)
  • Director reappointment, Concorde Consulting (director)
  • Director reappointment, Simbiosis.Life (director)
  • Director reappointment, Lammens Luc Marie Antoon Angèle (director)
  • Permanent representative, van Dongen Emilius Hubertus Adrianus Maria
  • Permanent representative, Reyn Dirk Maria Jozef
  • +3 further facts in this act
2025
16-05
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
27-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
20-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
04-07
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Liquidity more than doubledcurrent ratio 68.14
Current ratio from 26.28 to 68.14; short-term debt falls from €2,733 to €996.
28-06
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
30-06
NBB filing Annual accounts filed
financial year 2019 · micro format
2019
21-06
NBB filing Annual accounts filed
financial year 2018 · micro format
2018
25-06
NBB filing Annual accounts filed
financial year 2017 · micro format
2017
23-05
NBB filing Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 12 annual accounts filed, the latest 10 are here; all 12 are at the National Bank.
1 of 6 deeds read
About the unread acts

Of the 6 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure